GlassScriptPhysician profile
April M Shewmake
NPI 1932512050
$17,828.66
in general payments reported to CMS, 2019-2025
26 companies · $1,277 in 2025
The $1,277 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $136 · 2020: $270 · 2021: $2,889 · 2022: $3,744 · 2023: $7,850 · 2024: $1,662 · 2025: $1,277.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $6,533 · Food and Beverage: $4,256.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $6,533.29 |
| Food and Beverage | $4,255.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $11,568.48 | 2021-2025 | Resolute Onyx, Corevalve Evolut R, Onyx Frontier |
| Shockwave Medical, INC | $985.10 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave M5+ |
| Abiomed | $938.79 | 2020-2025 | Impella |
| Cardiovascular Systems INC. | $657.51 | 2020-2021 | |
| Philips North America LLC | $570.98 | 2019-2025 | Coronary Other |
| Boehringer Ingelheim Pharmaceuticals, INC. | $555.21 | 2021-2024 | Jardiance |
| Abbott Laboratories | $468.11 | 2021-2025 | Esprit, Diamondback Peripheral, Mitraclip |
| Boston Scientific Corporation | $376.68 | 2023-2025 | Avvigo Guidance System, Synergy, Wolverine Coronary Cutting Balloon |
| Asahi Intecc USA, INC. | $369.53 | 2020-2024 | Peripheral Vascular |
| Verge Medical, INC. | $214.24 | 2024 | |
| Inari Medical, INC. | $135.42 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Bard Peripheral Vascular, INC. | $130.72 | 2023-2024 | Crosser Iq, Pristine |
| Pfizer INC. | $119.69 | 2022-2024 | |
| Astrazeneca Pharmaceuticals LP | $100.43 | 2019-2022 | |
| Cardiva Medical, INC. | $98.53 | 2023-2024 | Cardiva Vascade 6/7f Vcs |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Livanova USA, INC. | $95.67 | 2023 | Tandemlife, Lifesparc |
| Edwards Lifesciences Corporation | $76.23 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $74.30 | 2022-2025 | Lifevest |
| Cook Medical LLC | $46.38 | 2023-2024 | Cook |
| Penumbra, INC. | $46.20 | 2022-2024 | Indigo System |
| Chiesi USA, INC. | $43.61 | 2020-2023 | Kengreal |
| Stryker Corporation | $35.72 | 2023 | N/A |
| Novartis Pharmaceuticals Corporation | $34.95 | 2025 | |
| Janssen Pharmaceuticals, INC | $30.11 | 2022-2024 | Xarelto |
| Teleflex LLC | $29.72 | 2024-2025 | Supercross, Orsiro Mission |
| Medtronic Vascular, INC. | $26.35 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw April Shewmake listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.